Huge Samsung BioLogics IPO Reflects Rosy Manufacturing Outlook

 
• By Jung Won Shin

Samsung BioLogics has successful floated in one of South Korea’s largest ever IPOs and appears to be on track to becoming the top global contract manufacturer of biologics amid rising demand from cost-conscious global clients.

More from Manufacturing

More from Business